Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


KSHV gene expression and regulation.

Schulz TF, Chang Y.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 28.


Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.

Purushothaman P, Thakker S, Verma SC.

J Virol. 2015 Mar;89(6):3093-111. doi: 10.1128/JVI.02507-14. Epub 2014 Dec 31.


Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.

Nicol SM, Sabbah S, Brulois KF, Jung JU, Bell AI, Hislop AD.

J Virol. 2016 Mar 28;90(8):3849-59. doi: 10.1128/JVI.02377-15. Print 2016 Apr.


Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.

Pan ZG, Zhang QY, Lu ZB, Quinto T, Rozenvald IB, Liu LT, Wilson D, Reddy V, Huang Q, Wang HY, Ren YS.

Am J Surg Pathol. 2012 Aug;36(8):1129-40. doi: 10.1097/PAS.0b013e31825b38ec. Erratum in: Am J Surg Pathol. 2013 Mar;37(3):458. Huang, Qing [corrected to Huang, Qin].


Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.

Blood. 1997 Aug 1;90(3):1186-91.


Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU.

J Virol. 2012 Sep;86(18):9708-20. doi: 10.1128/JVI.01019-12. Epub 2012 Jun 27.


Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.

Chandrasekharan JA, Huang XM, Hwang AC, Sharma-Walia N.

J Virol. 2016 Nov 28;90(24):11020-11031. Print 2016 Dec 15.


Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.

Lan K, Murakami M, Bajaj B, Kaul R, He Z, Gan R, Feldman M, Robertson ES.

Cancer Biol Ther. 2009 Nov;8(22):2136-43. Epub 2009 Nov 7.


The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.

Wies E, Mori Y, Hahn A, Kremmer E, St├╝rzl M, Fleckenstein B, Neipel F.

Blood. 2008 Jan 1;111(1):320-7. Epub 2007 Sep 21.


De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Lagunoff M, Bechtel J, Venetsanakos E, Roy AM, Abbey N, Herndier B, McMahon M, Ganem D.

J Virol. 2002 Mar;76(5):2440-8.


A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GS, Ambinder RF.

J Virol. 2000 Nov;74(21):10187-93.


Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).

Dai L, Trillo-Tinoco J, Bai L, Kang B, Xu Z, Wen X, Del Valle L, Qin Z.

PLoS One. 2014 Feb 28;9(2):e90349. doi: 10.1371/journal.pone.0090349. eCollection 2014.


Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM.

Histopathology. 2008 Nov;53(5):513-24. doi: 10.1111/j.1365-2559.2008.03144.x.


Alterations of mRNA splicing in primary effusion lymphomas.

Li Z, Pan L, Cesarman E, Knowles DM.

Leuk Lymphoma. 2003 May;44(5):833-40.


Supplemental Content

Support Center